Shares are down in the year to date and 20% off their 52-week high, but analysts see 30% upside ahead for Pfizer.

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...